Nov 3
Current report
8-K
Regulation FD disclosure, Other events
ACET · Adicet Bio, Inc. · Documents
$2.93
-0.06 (-2.01%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our recurring losses from operations incurred since inception, the expectation of continuing operating losses for the foreseeable future, our outstanding and future payment obligations, and the potential need to raise additional capital to finance our future operations, we have concluded that substantial doubt exists about our ability to continue as a going concern for a period at least twelve months from the date of issuance of these unaudited consolidated financial statements.”View the 10-Q filed Nov 5, 2026
Market Cap
$27.43M
Shares
9.36M
Volume · Nov 12
371.41K
Avg daily vol (3M)
226.86K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2022
Oct 5
Current report
8-K
Other events
Aug 10
Current report
8-K
Financial results
Aug 10
Quarterly report
10-Q
FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Net loss $22.54M
Diluted EPS -$0.56
Jun 21
Current report
8-K
Events of Jun 16
Entered into a material agreement
Jun 6
Current report
8-K
Regulation FD disclosure, Other events
Jun 3
Current report
8-K
Events of Jun 2
Shareholder vote results
May 26
Current report
8-K
Regulation FD disclosure, Other events
May 12
Current report
8-K
Financial results
May 12
Quarterly report
10-Q
FY2022 Q1, ended Mar 31
Quarterly report for FY2022 Q1
Net income $4.62M
Diluted EPS $0.10
May 5
Current report
8-K
Regulation FD disclosure
Apr 21
Proxy statement
DEF 14A
Meeting Jun 2, 2022
Proxy statement
Apr 21
Proxy statement
DEFA14A
Proxy statement
Apr 19
Current report
8-K
Regulation FD disclosure
Mar 24
Current report
8-K
Events of Mar 18
Entered into a material agreement
Mar 16
Registration statement
S-3/A
Registration statement
Mar 15
Current report
8-K
Financial results
Mar 15
Mar 15
Registration statement
S-3
Registration statement
Feb 3
Current report
8-K
Events of Jan 28
Other events
2021
Dec 10
Current report
8-K
Events of Dec 7
Entered into a material agreement, Other events
Dec 6
Current report
8-K
Other events
Nov 18
Current report
8-K
Events of Nov 17
Director or officer change, or executive pay, Regulation FD disclosure
Nov 12
Current report
8-K
Regulation FD disclosure, Other events
Nov 10
Current report
8-K
Financial results
Nov 10
Oct 29
Current report
8-K
Events of Oct 27
Ended a material agreement
Oct 25
Current report
8-K
Events of Oct 19
Entered into a material agreement
Sep 13
Current report
8-K
Regulation FD disclosure, Other events
Aug 16
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2020
Aug 12
Current report
8-K
Financial results
Aug 12
Jul 30
Current report
8-K
Events of Jul 29
Ended a material agreement
Jul 23
Current report
8-K
Events of Jul 19
Entered into a material agreement
Jul 1
Current report
8-K
Events of Jun 25
Entered into a material agreement
May 17
Current report
8-K/A
Events of May 11
Financial results, Director or officer change, or executive pay
May 17
Current report
8-K
Events of May 11
Financial results, Director or officer change, or executive pay
May 17
May 13
Registration statement
S-3
Registration statement
Apr 29
Current report
8-K
Events of Apr 27
Shareholder vote results
Apr 9
Current report
8-K
Events of Apr 7
Entered into a material agreement
Mar 18
Proxy statement
DEF 14A
Meeting Apr 27, 2021
Proxy statement
Mar 18
Proxy statement
DEFA14A
Proxy statement
Mar 12
Mar 12
Registration statement
S-3
Registration statement
Mar 11
Current report
8-K
Financial results
Mar 10
Current report
8-K
Other events
Mar 4
Current report
8-K
Events of Mar 2
Director or officer change, or executive pay
Feb 19
Current report
8-K
Events of Feb 16
Director or officer change, or executive pay
Feb 16
Current report
8-K
Events of Feb 10
Entered into a material agreement, Other events
Showing 101–150 of 187 documents
Key facts
CIK
1720580
CUSIP
007002207
13F (30d)
37 filings
25 filers
Visit website
Investor relations